168 related articles for article (PubMed ID: 9409275)
1. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis.
Laurila A; Bloigu A; Näyhä S; Hassi J; Leinonen M; Saikku P
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2910-3. PubMed ID: 9409275
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia pneumoniae antibodies associated with altered serum lipid profile.
Laurila AL; Bloigu A; Näyhä S; Hassi J; Leinonen M; Saikku P
Int J Circumpolar Health; 1998; 57 Suppl 1():329-32. PubMed ID: 10093301
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis.
Leinonen M; Saikku P
Am Heart J; 1999 Nov; 138(5 Pt 2):S504-6. PubMed ID: 10539859
[TBL] [Abstract][Full Text] [Related]
4. Association of Helicobacter pylori infection with elevated serum lipids.
Laurila A; Bloigu A; Näyhä S; Hassi J; Leinonen M; Saikku P
Atherosclerosis; 1999 Jan; 142(1):207-10. PubMed ID: 9920523
[TBL] [Abstract][Full Text] [Related]
5. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile.
Hoffmeister A; Rothenbacher D; Bode G; Persson K; März W; Nauck MA; Brenner H; Hombach V; Koenig W
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):427-32. PubMed ID: 11231924
[TBL] [Abstract][Full Text] [Related]
6. [Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease].
Duan Z; Liu S; Wang B
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):208-11. PubMed ID: 11802964
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays.
Tuuminen T; Varjo S; Ingman H; Weber T; Oksi J; Viljanen M
Clin Diagn Lab Immunol; 2000 Sep; 7(5):734-8. PubMed ID: 10973446
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile.
Murray LJ; O'Reilly DP; Ong GM; O'Neill C; Evans AE; Bamford KB
Heart; 1999 Mar; 81(3):239-44. PubMed ID: 10026343
[TBL] [Abstract][Full Text] [Related]
9. [Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease].
Márk L; Márki-Zay J; Orosz I; Kondacs A; Erdei F; Katona A
Orv Hetil; 2003 Apr; 144(16):765-8. PubMed ID: 12778627
[TBL] [Abstract][Full Text] [Related]
10. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease.
Toss H; Gnarpe J; Gnarpe H; Siegbahn A; Lindahl B; Wallentin L
Eur Heart J; 1998 Apr; 19(4):570-7. PubMed ID: 9597405
[TBL] [Abstract][Full Text] [Related]
11. Effect of acute Chlamydia pneumoniae infection on lipoprotein metabolism in NIH/S mice.
Tiirola T; Erkkilä L; Laitinen K; Leinonen M; Saikku P; Bloigu A; Jauhiainen M
Scand J Clin Lab Invest; 2002; 62(6):477-84. PubMed ID: 12469903
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure.
Song H; Tasaki H; Yashiro A; Okazaki M; Ioka T; Taniguchi H; Nakashima Y
Clin Nephrol; 2001 Nov; 56(5):346-52. PubMed ID: 11758004
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
[TBL] [Abstract][Full Text] [Related]
14. Relationship between dyslipidemia, C-reactive protein and serological evidence of Chlamydia pneumoniae in Turkish patients with coronary artery diseases.
Turkoglu C; Sonmez E; Aydinli A
New Microbiol; 2004 Jul; 27(3):229-34. PubMed ID: 15460525
[TBL] [Abstract][Full Text] [Related]
15. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Chlamydia pneumoniae infection in patients with coronary artery disease subjected to angioplasty or bypass surgery.
Pieniazek P; Karczewska E; Stepień E; Tracz W; Konturek SJ
Med Sci Monit; 2001; 7(5):995-1001. PubMed ID: 11535948
[TBL] [Abstract][Full Text] [Related]
17. A pilot study on the association between double positive Chlamydia pneumoniae serology and serum lipid indices alterations in obese adult females.
Jaworowska A; Bazylak G
Life Sci; 2011 Dec; 89(23-24):854-61. PubMed ID: 21983298
[TBL] [Abstract][Full Text] [Related]
18. Possible role of chronic infection with Chlamydia pneumoniae in Japanese patients with acute myocardial infarction.
Kosaka C; Hara K; Komiyama Y; Takahashi H
Jpn Circ J; 2000 Nov; 64(11):819-24. PubMed ID: 11110424
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of Chlamydophila pneumoniae seropositivity and risk factors in patients with atherosclerotic vascular disease in Sivas, Turkey].
Kılıç ZB; Poyraz O; Kılıç AT
Mikrobiyol Bul; 2012 Jan; 46(1):156-8. PubMed ID: 22399186
[TBL] [Abstract][Full Text] [Related]
20. [Chlamydia pneumoniae and cerebrovascular disease].
Linares-Palomino J; Gutiérrez J; López-Espada C; Ros E; Moreno J; Pérez T; Rodríguez M; Maroto MC
Rev Neurol; 2001 Feb 1-15; 32(3):201-6. PubMed ID: 11310268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
